Elevance Health, Inc. (NYSE:ELV) Shares Sold by Blair William & Co. IL

Blair William & Co. IL lessened its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 54.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,056 shares of the company's stock after selling 8,580 shares during the quarter. Blair William & Co. IL's holdings in Elevance Health were worth $2,603,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Mutual Advisors LLC increased its stake in shares of Elevance Health by 2.5% in the fourth quarter. Mutual Advisors LLC now owns 2,163 shares of the company's stock worth $833,000 after acquiring an additional 52 shares during the period. Czech National Bank raised its stake in shares of Elevance Health by 6.5% during the 4th quarter. Czech National Bank now owns 50,286 shares of the company's stock valued at $18,551,000 after buying an additional 3,049 shares during the last quarter. Diversified Trust Co lifted its holdings in shares of Elevance Health by 13.7% in the 4th quarter. Diversified Trust Co now owns 22,576 shares of the company's stock valued at $8,328,000 after buying an additional 2,725 shares during the period. JB Capital LLC grew its holdings in Elevance Health by 597.2% during the fourth quarter. JB Capital LLC now owns 9,384 shares of the company's stock worth $3,462,000 after acquiring an additional 8,038 shares during the period. Finally, Tidal Investments LLC raised its position in Elevance Health by 60.6% during the third quarter. Tidal Investments LLC now owns 10,485 shares of the company's stock valued at $5,452,000 after acquiring an additional 3,956 shares in the last quarter. 89.24% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Insider Activity

In other Elevance Health news, EVP Charles Morgan Kendrick, Jr. sold 3,504 shares of Elevance Health stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $396.30, for a total transaction of $1,388,635.20. Following the completion of the sale, the executive vice president now directly owns 10,116 shares in the company, valued at $4,008,970.80. This trade represents a 25.73 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ronald W. Penczek sold 443 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $415.13, for a total transaction of $183,902.59. Following the completion of the transaction, the chief accounting officer now owns 1,847 shares in the company, valued at approximately $766,745.11. This represents a 19.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ELV. Argus raised shares of Elevance Health from a "hold" rating to a "buy" rating and set a $450.00 price objective on the stock in a research note on Monday, March 17th. Stephens cut shares of Elevance Health from an "overweight" rating to an "equal weight" rating and cut their price objective for the company from $520.00 to $440.00 in a report on Wednesday, January 22nd. Cantor Fitzgerald reiterated an "overweight" rating and issued a $485.00 price objective on shares of Elevance Health in a research report on Friday, January 24th. Wells Fargo & Company dropped their target price on Elevance Health from $483.00 to $478.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Finally, Truist Financial dropped their price objective on Elevance Health from $520.00 to $480.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Elevance Health currently has an average rating of "Moderate Buy" and an average target price of $519.81.

Elevance Health Price Performance

Shares of NYSE:ELV traded up $23.37 during midday trading on Thursday, hitting $452.70. The company's stock had a trading volume of 3,314,748 shares, compared to its average volume of 1,403,069. The company has a market cap of $102.48 billion, a P/E ratio of 17.68, a price-to-earnings-growth ratio of 1.18 and a beta of 0.77. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.50 and a current ratio of 1.45. Elevance Health, Inc. has a 12-month low of $362.21 and a 12-month high of $567.26. The business's 50 day simple moving average is $407.13 and its 200 day simple moving average is $418.89.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping analysts' consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. On average, analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th were paid a dividend of $1.71 per share. The ex-dividend date of this dividend was Monday, March 10th. This is an increase from Elevance Health's previous quarterly dividend of $1.63. This represents a $6.84 dividend on an annualized basis and a yield of 1.51%. Elevance Health's payout ratio is 26.71%.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.